This Breakthrough Cancer Treatment Engineers a Patient’s Own Blood Cells

The FDA just approved a first-of-its-kind treatment for individuals with blood cancer that has proven results of 5-year survival rates. Christi Shaw, CEO of Kite, a Gilead company, joins Cheddar Innovates to discuss how this treatment works and compares to others currently on the market.

Apr 21, 2022

More Videos

What Happens When a Driverless Car Needs a Pit Stop?

Aseon Labs CEO George Kalligeros explains how robotic pit stops could keep autonomous vehicle fleets charged, serviced, and on the road 24/7.

OpenAI vs. Apple: The AI Fight That Could Change Everything

Fast Company's Christopher Zara breaks down the OpenAI-Apple legal battle, the AI chip race, and what's next for the future of artificial intelligence.

The AI Robots Changing Recycling Forever

Glacier CEO Rebecca Hu-Thrams explains how AI-powered robots are making recycling smarter, reducing landfill waste, and transforming the future of waste.

What Are "Freedom Fuel" Gas Stations—and Could They Save You Money?

USA TODAY's Keith Laing explains the White House's new "Freedom Fuel" initiative, what it means for gas prices, E15 fuel, and drivers across America.

The Female CEO Leading a New Chapter in Nuclear Power

Deep Fission CEO Liz Muller discusses underground nuclear reactors, powering AI, cutting energy costs, and why the future of clean power may be below ground.

Ai Job Disruption Warning Grows Louder

A growing chorus of economists, business leaders, and labor experts is warning that artificial intelligence could reshape the workforce faster than thought.

Apple Opens Its Next-generation Siri To The Public

Apple has released the public beta of iOS 27, giving users broad access to its redesigned AI-powered Siri for the first time.

OpenAI’s First Device May Have No Screen At All

OpenAI’s long-rumored consumer hardware project is reportedly taking an unconventional approach with a screenless AI-powered device that can move like a tablet.